Concepedia
Statistics
Publications
8
Citations
372
H-Index
Active since
1998
Affiliations
Ono Pharmaceutical (United States)(Current)
Medical University of South Carolina
MUSC Hollings Cancer Center
University of Miami
Eric M. Grund is an author at Ono Pharmaceutical (United States) specializing in immunology, medicine, and genetic engineering.
Top concepts
MedicineImmunologyVaccinationCell BiologyPharmacologyGene DeliveryGene TransferImmunotherapyGenome EditingCross-protection
Publications per year
1998–2022
Tumor Necrosis Factor-α Regulates Inflammatory and Mesenchymal Responses via Mitogen-Activated Protein Kinase Kinase, p38, and Nuclear Factor κB in Human Endometriotic Epithelial Cells
Eric M. Grund, David Kagan, Cam Anh Tran et al. · Molecular Pharmacology · 2008 · 130 citations
Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine
Lendon G. Payne, Sharon Jenkins, Angela Woods et al. · Vaccine · 1998 · 107 citations
Vaccination, Cross-protection, Vaccine Development +8
Interleukins 2 and 15 Regulate Ets1 Expression via ERK1/2 and MNK1 in Human Natural Killer Cells
Eric M. Grund, Demetri D. Spyropoulos, Dennis K. Watson et al. · Journal of Biological Chemistry · 2004 · 39 citations · Full text
Cost efficient and effective gene transfer into the human natural killer cell line, NK92
Eric M. Grund, Robin C. Muise‐Helmericks · Journal of Immunological Methods · 2004 · 33 citations
Xenotransplantation, Cost Efficient, Immunology +10
A Long-Acting Tumor Necrosis Factor α-Binding Protein Demonstrates Activity in Both In Vitro and In Vivo Models of Endometriosis
Z. Melis Altan, Deborah Denis, David Kagan et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 27 citations
1–5 of 8